Mergers & Acquisitions Mergers & Acquisitions

ChrysCapital removes director from competing Indian firm to expand stake in Intas Pharmaceuticals

By Freny Patel
  • 21 Dec 2020 07:11
  • 21 Dec 2020 07:11
Private equity investor ChrysCapital was forced to remove its director from the board of Mankind Pharma and will not be able to exercise its veto rights in the company as a condition of securing merger clearance from the Indian competition authority to increase its minority stake in Intas Pharmaceuticals.

The Competition Commission of

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News